ACT CAPITAL MANAGEMENT, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 32 filers reported holding INMUNE BIO INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2022$937,000
-34.0%
151,100
-5.9%
1.29%
-34.9%
Q2 2022$1,419,000
-26.9%
160,500
-30.4%
1.98%
-3.4%
Q1 2022$1,941,000
-17.4%
230,5000.0%2.05%
+20.8%
Q4 2021$2,351,000
-56.0%
230,500
-16.2%
1.70%
-38.6%
Q3 2021$5,341,000275,0002.77%
Other shareholders
INMUNE BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders